This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Massachusetts-based Boston Properties, Inc. — the real estate investment trust (REIT) — owns and develops Class A office real estates in the United States. The company also owns interest in 13 retail properties, six residential properties and a hotel. Its properties are concentrated in five core markets: Boston, Los Angeles, New York, San Francisco and Washington, DC. These regions comprise traditional tenants, like government, financial services and law firms as well as businesses involving technology, advertising, media, life sciences and medical devices.
BXP Stock Rallies 30.4% in 3 Months: Will it Continue to Rise?
by Zacks Equity Research
BXP is set to gain from a rise in demand for top-quality office spaces driven by technology, life science business and its prudent capital-management practices.
BXP Rallies 19.5% in 3 Months: Will It Continue to Rise?
by Zacks Equity Research
BXP's assets in a few select markets, diversified tenant base, strategic expansions and a solid balance sheet position bode well for future growth.
Ventas (VTR) Q2 FFO Beats Estimates on Higher Same-Store NOI
by Zacks Equity Research
Ventas' (VTR) Q2 results reflect occupancy and revenue growth in its same-store senior housing operating portfolio.
Do Options Traders Know Something About BXP Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to BXP stock based on the movements in the options market lately.
BXP's Q2 FFO Outpaces Estimates, Lease Revenues Rise Y/Y
by Zacks Equity Research
BXP's Q2 results beat estimates on better-than-anticipated revenues, aided by healthy leasing activity. It has raised the 2024 FFO per share guidance.
Compared to Estimates, Boston Properties (BXP) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Boston Properties (BXP) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Boston Properties (BXP) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Boston Properties (BXP) delivered FFO and revenue surprises of 2.91% and 1.18%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Iron Mountain (IRM) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Iron Mountain's (IRM) Q2 results are likely to be aided by strength in core storage and record management businesses and solid data center demand. However, high interest expenses remain a concern.
BXP Gears Up to Report Q2 Earnings: Key Factors to Consider
by Zacks Equity Research
BXP's Q2 earnings are likely to have benefited from healthy demand for premium office and life-science assets. However, high interest rates remain a concern.
Is it Wise to Retain Boston Properties (BXP) Stock for Now?
by Zacks Equity Research
Healthy demand for premier office spaces and long-term leases from tenants bode well for Boston Properties (BXP). However, elevated interest rates continue to be a concern.
Ventas (VTR) Q1 FFO Beats Estimates on Higher Same-Store NOI
by Zacks Equity Research
Ventas' (VTR) Q1 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves year over year on strong performance.
Boston Properties (BXP) Q1 FFO Meet Estimates, '24 View Lowered
by Zacks Equity Research
Boston Properties' (BXP) Q1 results meet estimates on better-than-anticipated revenues, aided by healthy leasing activity. It lowers the 2024 FFO per share guidance.
Here's What Key Metrics Tell Us About Boston Properties (BXP) Q1 Earnings
by Zacks Equity Research
The headline numbers for Boston Properties (BXP) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Boston Properties (BXP) Q1 FFO Meet Estimates
by Zacks Equity Research
Boston Properties (BXP) delivered FFO and revenue surprises of 0% and 2.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Host Hotels (HST) in Q1 Earnings?
by Zacks Equity Research
Host Hotels' (HST) Q1 earnings are likely to have benefited from the continued recovery in group travel and business transient demand. However, high interest expenses raise concerns.
Iron Mountain (IRM) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Strength in core storage and record management businesses and solid data center demand are likely to have aided Iron Mountain's (IRM) Q1 earnings. However, high interest expenses remain a concern.
Should You Buy Boston Properties (BXP) Ahead of Earnings?
by Zacks Equity Research
Boston Properties (BXP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Key Factors to Impact Boston Properties' (BXP) Q1 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q1 earnings. However, high interest expenses remain a concern.
Alexandria (ARE) Beats Q1 AFFO Estimates, Narrows '24 Guidance
by Zacks Equity Research
Alexandria's (ARE) Q1 results reflect healthy leasing activity and rental rate growth.
Stock Market News for Apr 11, 2024
by Zacks Equity Research
Wall Street closed sharply lower on Wednesday, in a broad-based slump.
Boston Properties (BXP) Closes Stake Sale in Kendall Square Asset
by Zacks Equity Research
Boston Properties' (BXP) latest stake sale helps it capitalize on the value that investors are placing on well-positioned, well-managed and well-leased premier workplaces.
Is it Wise to Retain Boston Properties (BXP) Stock for Now?
by Zacks Equity Research
Healthy demand for premier office spaces and life-science portfolio expansion bode well for Boston Properties (BXP). Overall office real estate market choppiness and high interest rates are woes.
Ventas' (VTR) Q4 FFO Meets Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Ventas' (VTR) Q4 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves across the portfolio. It has also issued its 2024 outlook.
Welltower (WELL) Q4 FFO Beat Estimates, SHO Occupancy Rises
by Zacks Equity Research
Welltower's (WELL) Q4 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year.
Healthpeak's (PEAK) Q4 FFO Beat Estimates, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (PEAK) Q4 results outshine estimates on better-than-anticipated revenues. Same-store cash NOI for the total portfolio improves year over year. It has issued its 2024 outlook.